Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells

Blood

Volumn 92, Issue 9, 1998, Pages 3381-3387

  Voorzanger Rousselot, Nathalie ^a   Favrot, M C ^a   Blay, Jean Yves ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; DOXORUBICIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032213376     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3381     Document Type: Article

References (45)

1. Shipp M: Prognostic factors in agressive non Hodgkin's lymphoma: Who has high risk disease. Blood 83:1165, 1994
2. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, Coiffier B, Biron P, Mandelli F, Chauvin F: Autologous bone marrow transplantation as compared to salvage chemotherapy in relapses of chemotherapy-sensitive non Hodgkin's lymphoma. N Engl J Med 333:1540, 1995
3. Miller TP, Chase EM, Dalton WS, Grogan TM: The phenomenon of multidrug resistance in non Hodgkin's lymphoma, in Cabanillas F, Rodriguez A (eds): Advances in Lymphoma Research. Boston, MA, Kluwer, 1997, p 107
4. Kerr JFR, Wyllie AH Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239, 1972
5. Goldstein P, Ojcius DM, Young JDE: Cell death mechanisms and the immune system. Immunol Rev 121:29, 1991
6. Raff MC: Social controls on cell survival and cell death. Nature 356:397, 1992
7. Thompson CB: Apoptosis in the pathogenesis and the treatment of disease. Science 267:1456, 1995
8. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181, 1989
9. Servomaa K, Rytomaa T: UV light and ionizing radiations cause programmed death of rat chloroleukaemia cells inducing retropositions of a mobile DNA element (L1Rn). Int J Radiat Biol 57:331, 1990
10. Nagata S, Goldstein P: The Fas death factor. Science 267:1449, 1995
11. Duke RC, Cohen JJ: IL 2 addiction. Lymphokine Res 5:289, 1986
12. Rodriguez TG, Collins M, Lopez RA: Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 9:2997, 1990
13. Kaufman SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptotecin, and other cytotoxic anti-cancer drugs: A cautionary note. Cancer Res 49:5870, 1989
14. Sen S, D'Incalci M: Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307:122, 1992
15. Kondo S, Yin D, Morimura T, Kubo H, Nakatsu S, Takeuchi J: Combination therapy with cisplatin and nifepidine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br J Cancer 71:282, 1995
16. Datta R, Banach D, Kojima H, Talanian RV, Amemri ES, Wong WW, Kufe DW: Activation of the CPP32 protease in apoptosis induced by 1-b-D arabinofuranosyl cytosine and other DNA damaging agents. Blood 88:1936, 1996
17. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med 2:574, 1996
18. Gruss HJ, Dower SK: Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85,12:3378, 1995
19. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Lui YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 12:881, 1994
20. Lui YJ, Williams GT, Smith CA, Gordon J, Maclennan ICM: Mechanisms of antigen driven selection in germinal centers. Nature 342:929, 1989
21. Schattner J, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM: CD40 ligation induces Apo-1/Fas expression on human lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557, 1995
22. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265, 1995
23. Demidem A, Lam D, Gan X-H, Levine A, Salahuddin Z, Bonavida B: Endogenous IL-10 is a protective factor in drug resistant AIDS-related lymphoma. Proc Am Assoc Cancer Res 36:323a, 1995 (abstr)
24. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC: Interleukin 6 inhibits Fas-induced apoptosis and stress activated protein kinase activation in multiple myeloma cells. Blood 89:227, 1997
25. Schwarze MM, Hawley RG: Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res 55:2262, 1995
26. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179:91, 1994
27. Levy Y, Brouet JC: Interleukin-10 prevents spontaneous death of germinal center B cells by induction of bcl-2 protein. J Clin Invest 93:424, 1994
28. Lotem J, Sachs L: Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ 6:647, 1995
29. Armant M, Delespesse G, Sarfati M: IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology 85:331, 1995
30. Adachi M, Sekiya M, Torigoe T, Takayama S, Reed JC, Miyazaki T, Minami Y, Taniguchi T, Imai K: Interleukin-2 (IL-2) upregulates BAG-l gene expression through serine-rich region within IL-2 receptor beta c chain. Blood 88:4118, 1996
31. Voorzanger N, Touitou R, Garcia E, Delecluse HJ, Rousset F, Joab I, Favrot MC, Blay JY: Interleukin (IL)-10 and IL-6 are produced in vivo by non Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 56:5499, 1996
32. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin P, Labelie M, Lazbenik YA, Munday NA, Raju SM, Smulson ME, Yamin TT, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
33. Fernandas-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 78:739, 1994
34. Muller C, Chatelut E, Gualano V, De Forni M, Huguet F, Attal M, Canal P, Laurent G: Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: Comparison of bolus administration and continuous infusion. Cancer Chemother Pharmacol 32:379, 1993
35. Ghia P, Boussiotis VA, Schultze JL, Cardoso AA, Dorfman DM, Gribben JG, Freedman AS, Nadler LM: Unbalanced expression of bcl-2 family proteins in follicular lymphoma: Contribution of CD40 signalling in promoting survival. Blood 91:244, 1998
36. Finke J, Molto L, Bloom T, Kolenko V, Pohlman B, Lichtin A, McLain D, Tubbs R, Bukowski RM: CD40L is not expressed on T cell infiltrating non Hodgkin's lymphoma B cells and is poorly induced after stimulation. Blood 90:76a, 1997 (abstr, suppl 1)
37. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC: Serum interleukin 10 in non Hodgkin's lymphoma: A prognostic factor. Blood 82:2169, 1993
38. Stasi R, Zinzani PL, Galieni P, Lama VM, Damasio E, Dispensa E, Dammaco F, Tura S, Papa G: Detection of soluble interleukin 2 receptor and interleukin 10 in the serum of patients with aggressive non Hodgkin's lymphoma. Cancer 74:1792, 1994
39. Seymour JF, Talpaz M, Cabanillas F, Wetzler M, Kurzrock R: Serum IL-6 levels correlate with prognosis in diffuse large cell lymphoma. J Clin Oncol 13:575, 1995
40. Dubrez L, Savoy I, Hamman A, Solary E: Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas mediated apoptotic pathways. EMBO J 15:5504, 1996
41. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782, 1996
42. Wang CY, Mayo MW, Baldwin AS Jr: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784, 1996
43. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787, 1996
44. Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424, 1995
45. Walker A, Taylor ST, Hickman JA, Dive C: Germinal center derived signals act with bcl-2 to decrease apoptosis and increase clonogenicity of drug treated human B lymphoma cells. Cancer Res 57:1939, 1997